We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.14%
2 Financials 4.52%
3 Industrials 4.17%
4 Healthcare 3.91%
5 Consumer Discretionary 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATH icon
8601
Metalpha Technology Holding
MATH
$40.8M
$45K ﹤0.01%
33,556
+7,564
+29% +$10.5K
SUP
8602
CALL
DELISTED
Superior Industries International
SUP
$45K ﹤0.01%
12,200
-4,500
-27% -$13.7K
TOO
8603
CALL
DELISTED
Teekay Offshore Partners L.P.
TOO
$45K ﹤0.01%
29,000
-20,300
-41% -$31.2K
ADMA icon
8604
CALL
ADMA Biologics
ADMA
$2.25B
$44K ﹤0.01%
11,100
-200
-2% -$872
BNED icon
8605
PUT
Barnes & Noble Education
BNED
$438M
$44K ﹤0.01%
+103
New +$42.3K
MBIO icon
8606
PUT
Mustang Bio
MBIO
$4.36M
$44K ﹤0.01%
+14
New +$32.1K
REI icon
8607
Ring Energy
REI
$333M
$44K ﹤0.01%
16,370
-2,227
-12% -$4.37K
MDVL
8608
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$44K ﹤0.01%
+61
New +$51.9K
INFI
8609
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$44K ﹤0.01%
45,384
+17,950
+65% +$19.7K
BLNK icon
8610
Blink Charging
BLNK
$77.6M
$43K ﹤0.01%
23,139
+8,096
+54% +$16.9K
CLDX icon
8611
CALL
Celldex Therapeutics
CLDX
$3.26B
$43K ﹤0.01%
19,400
+6,800
+54% +$15.8K
STGW icon
8612
PUT
Stagwell
STGW
$2.23B
$43K ﹤0.01%
+15,500
New +$41.8K
ONIT
8613
Onity Group
ONIT
$311M
$43K ﹤0.01%
2,093
-387
-16% -$9.37K
SDRL
8614
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
$43K ﹤0.01%
16,900
+6,900
+69% +$11.4K
BTE icon
8615
CALL
Baytex Energy
BTE
$2.89B
$42K ﹤0.01%
29,300
+2,000
+7% +$2.47K
IBRX icon
8616
CALL
ImmunityBio
IBRX
$7.76B
$42K ﹤0.01%
+11,000
New +$18.7K
LXRX icon
8617
PUT
Lexicon Pharmaceuticals
LXRX
$1.05B
$42K ﹤0.01%
10,100
-3,500
-26% -$13.5K
MTC icon
8618
MMTec
MTC
$298M
$42K ﹤0.01%
+263
New +$48.9K
PPSI
8619
Pioneer Power Solutions
PPSI
$33.5M
$42K ﹤0.01%
+18,416
New +$58K
CORV
8620
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$42K ﹤0.01%
+102,129
New +$170K
REFR icon
8621
Research Frontiers
REFR
$16.3M
$41K ﹤0.01%
13,662
-18,020
-57% -$57.8K
ACOR
8622
CALL
DELISTED
Acorda Therapeutics
ACOR
$41K ﹤0.01%
168
+37
+28% +$9.34K
YELL
8623
PUT
DELISTED
Yellow Corporation Common Stock
YELL
$41K ﹤0.01%
+16,100
New +$55.2K
ALT icon
8624
CALL
Altimmune
ALT
$585M
$40K ﹤0.01%
21,200
+1,400
+7% +$2.59K
UXIN
8625
PUT
Uxin Ltd
UXIN
$222M
$40K ﹤0.01%
175
-114
-39% -$30.8K

Similar funds

Citadel Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.

Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.

  • Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
  • Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.